18+

CELLIVITY / ADULT ACCESS

Are you 18 or older?

CELLIVITY is available to adults only. Supplement pages are general product information; peptide records are not a sales offer and are not for human use.

Age confirmation is a declaration, not identity verification. Restricted research access still requires separate professional eligibility checks.Privacy and legal notice ↗
Skip to content
CELLIVITY
HomeScience LibraryEvidence methodologyResearch Radar
🇬🇧EN⌄
🇬🇧EnglishEN🇭🇺MagyarHU🇹🇭ไทยTH🇷🇺РусскийRU
Independent evidence
HomeScience LibraryEvidence methodologyResearch Radar
← Science Library

NAD+ biology

NMN

Nicotinamide mononucleotide

Guide-level evidence orientationEvidence level C

Level C describes limited, mixed or context-dependent human evidence for this exact question; read the conclusion for direction and limits.

This guide-level grade is an orientation, not a direction-of-effect label, product grade, claim or personal recommendation.
ORIENTATION RECORDUseful starting context; question-specific review is still pending.

Do not treat the guide-level letter as a final conclusion, product claim or recommendation.

IN PLAIN LANGUAGE

Why people are interested

A raw material the body can use to make NAD+, a molecule involved in cellular energy. It can change biomarkers, but lasting benefits remain uncertain.

Library trackResearch Radar
Last reviewed20 Aug 2026
Guide scopeIngredient research only
01

How it may work

A biosynthetic precursor in NAD+ metabolism.

02

What people have studied

Short trials show biomarker and selected functional signals; durable clinical benefit and long-term safety remain uncertain.

03

What to consider

Long-term, population-specific safety is not established.

04

Local pathway

Novel-food and source review required; no definitive positive-list route identified.

Sources + indexes

See where the explanation comes from.

Open the linked research and official records behind this guide. Early topics may begin with a research index while stronger sources are added.

  1. 01NMN randomised controlled trial ↗
CELLIVITY

Independent evidence guides for human research.

Science LibraryHomeScience LibraryEvidence methodologyResearch Radar
BoundariesLegal and privacySafety boundariesPrivacy request / unsubscribe
Pre-release boundary

Unless a page explicitly says released, every product is a development record. No page confirms approval, stock, individual suitability or medical benefit. Educational content is not medical advice.

Full legal terms →
© 2026 CELLIVITY. Pre-launch.Riviera Jomtien, 29/111, Pattaya 20150, ThailandControlled contact route

CELLIVITY / STAY IN THE LOOP

Follow the next
chapter.

New product records, laboratory documents and release news. Choose to hear from us when there is something useful to share.

  • New laboratory documents
  • Product availability updates
  • News from CELLIVITY
18+ only. Optional email updates. You can unsubscribe at any time.
NMN — CELLIVITY Science Library